IL121789A - A medicinal product for inhibiting mammalian cell tumors - Google Patents

A medicinal product for inhibiting mammalian cell tumors

Info

Publication number
IL121789A
IL121789A IL12178997A IL12178997A IL121789A IL 121789 A IL121789 A IL 121789A IL 12178997 A IL12178997 A IL 12178997A IL 12178997 A IL12178997 A IL 12178997A IL 121789 A IL121789 A IL 121789A
Authority
IL
Israel
Prior art keywords
halo
alkyl
alkynyl
alkenyl
cyano
Prior art date
Application number
IL12178997A
Other languages
English (en)
Hebrew (he)
Other versions
IL121789A0 (en
Original Assignee
Rohm & Haas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohm & Haas filed Critical Rohm & Haas
Publication of IL121789A0 publication Critical patent/IL121789A0/xx
Publication of IL121789A publication Critical patent/IL121789A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/423Oxazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/428Thiazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
IL12178997A 1996-10-03 1997-09-17 A medicinal product for inhibiting mammalian cell tumors IL121789A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2758396P 1996-10-03 1996-10-03

Publications (2)

Publication Number Publication Date
IL121789A0 IL121789A0 (en) 1998-02-22
IL121789A true IL121789A (en) 2001-06-14

Family

ID=21838567

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12178997A IL121789A (en) 1996-10-03 1997-09-17 A medicinal product for inhibiting mammalian cell tumors

Country Status (9)

Country Link
US (1) US6140362A (pt)
EP (1) EP0834311A1 (pt)
JP (1) JPH10114651A (pt)
KR (1) KR19980032504A (pt)
AU (1) AU737454B2 (pt)
BR (1) BR9704968A (pt)
CA (1) CA2216265A1 (pt)
IL (1) IL121789A (pt)
ZA (1) ZA978494B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229027A1 (en) * 1996-06-28 2002-08-07 Dow AgroSciences LLC Heterocyclic N-acetonylbenzamides and their use as fungicides
US6500405B1 (en) * 1996-11-14 2002-12-31 Dow Agrosciences Llc Use of certain amides as probes for detection of antitubulin activity and resistance monitoring
ZA983331B (en) * 1997-05-01 1998-10-27 Allegheny University Of The He Method for treating protozoal infections
AU2090099A (en) * 1997-12-16 1999-07-05 William Darwin Garner Reduction of uv induced skin cancer by topical amines
JP4143787B2 (ja) 1999-07-28 2008-09-03 味の素株式会社 α−アミノハロメチルケトン誘導体の製造方法
EP1553831A4 (en) * 2002-06-17 2007-11-07 Dow Agrosciences Llc PROCESS FOR SCREENING FUNGITOXIC COMPOUNDS
US7375093B2 (en) 2002-07-05 2008-05-20 Intrexon Corporation Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
UA87884C2 (uk) * 2004-12-03 2009-08-25 Мерк Энд Ко., Инк. Безводна кристалічна калієва сіль інгібітора віл-інтегрази
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
CN113387781A (zh) * 2021-07-16 2021-09-14 大连凯飞化学股份有限公司 一种α-卤代酮类化合物的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3661991A (en) * 1969-05-29 1972-05-09 Rohm & Haas N-(1,1-dialkyl-3-chloroacetonyl) benzamides
JPS5622790A (en) * 1979-07-31 1981-03-03 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
DE3132656C2 (de) * 1980-08-19 1986-09-04 Terumo Corp., Tokio/Tokyo Extrakt aus der Rinde des Nim-Baumes (Melia azadirachta) mit antineoplastischer Wirkung
WO1982001188A1 (en) * 1980-10-08 1982-04-15 Takeda Chemical Industries Ltd 4,5-deoxymaytansinoide compounds and process for preparing same
DK167984A (da) * 1983-03-30 1984-10-01 Lilly Industries Ltd Alkaloidderivater
US4863940A (en) * 1984-07-26 1989-09-05 Rohm And Haas N-acetonyl-substituted amides and phytopathogenic fungicidal use thereof
US4822902A (en) * 1984-07-26 1989-04-18 Rohm And Haas Company N-acetonylbenzamides and their use as fungicides
US4701406A (en) * 1984-11-16 1987-10-20 Trustees Of Boston University Assay for the detection of epigenetic toxic (non-genotoxic) substances
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
US4707498A (en) * 1986-01-14 1987-11-17 Merrell Dow Pharmaceuticals Inc. Fluorinated diaminoalkyne derivatives
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
US5003056A (en) * 1987-12-24 1991-03-26 Nippon Kayaku Kabushiki Kaisha Antibiotic NK86-0279, process for production of the same and application of the same
US5238941A (en) * 1988-03-25 1993-08-24 Ciba-Geigy Corporation Arylhydrazones and pharmaceutical compositions thereof
US4950761A (en) * 1988-04-04 1990-08-21 Southern Research Institute (S)-[6-amino-4-[(1-methyl-2-oxo-2 phenyl-ethyl amino]-5-nitro-2-pyridinyl]ca
US5304572A (en) * 1992-12-01 1994-04-19 Rohm And Haas Company N-acetonylbenzamides and their use as fungicides
US5254584A (en) * 1992-12-18 1993-10-19 Rohm And Haas Company N-acetonylbenzamides and their use as fungicides

Also Published As

Publication number Publication date
CA2216265A1 (en) 1998-04-03
JPH10114651A (ja) 1998-05-06
KR19980032504A (ko) 1998-07-25
BR9704968A (pt) 1998-10-27
AU737454B2 (en) 2001-08-23
MX9707574A (es) 1998-06-28
ZA978494B (en) 1998-03-26
EP0834311A1 (en) 1998-04-08
IL121789A0 (en) 1998-02-22
AU3835697A (en) 1998-04-09
US6140362A (en) 2000-10-31

Similar Documents

Publication Publication Date Title
AU2005301962B2 (en) Mediators of hedgehog signaling pathways, compositions and uses related thereto
JP5764555B2 (ja) 治療組成物および関連する使用方法
KR101383228B1 (ko) A3 아데노신 수용체 알로스테릭 조절제
JP5670266B2 (ja) フラザノベンゾイミダゾール
JP2009542679A (ja) キナーゼカスケードを調節するための二環式組成物および方法
JP2015536308A (ja) ガンの治療方法
JP2009542679A5 (pt)
AU2015314772B2 (en) Compositions and methods for treatment of prostate carcinoma
JP2021503013A (ja) Acss2阻害剤およびその使用方法
JP2018514524A (ja) 5−芳香族アルキニル基置換ベンズアミド系化合物並びにその製造方法、薬物組成物及び使用
WO2011137587A1 (en) Cytokine inhibitors
WO2020029980A1 (en) Smad3 inhibitors
US6140362A (en) Method for inhibiting the growth of mammalian cells
KR20190112292A (ko) 자가 면역 질환을 치료하기 위한 ror-감마 조절 인자로서의 n-{[2-(피페리딘-1-일)페닐](페닐)메틸}-2-(3-옥소-3,4-디하이드로-2h-1,4-벤족사진-7-일)아세트아미드 유도체 및 관련 화합물
Chen et al. Discovery of 2, 5-diphenyl-1, 3, 4-thiadiazole derivatives as HDAC inhibitors with DNA binding affinity
Abd Hamid et al. Design and synthesis of 1‑sec/tert‑butyl-2-chloro/nitrophenylbenzimidazole derivatives: Molecular docking and in vitro evaluation against MDA-MB-231 and MCF-7 cell lines
TW202116734A (zh) 乙醯輔酶a合成酶短鏈2(acss2)之小分子抑制劑
EP3000814A1 (en) Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors
CN103906751A (zh) 作为晚期SV40因子(LSF)抑制剂用于治疗癌症的[1,3]二氧杂环戊烯并[4,5-g]喹啉-6(5H)-硫酮和[1,3]二氧杂环戊烯并[4,5-g][1,2,4]三唑并[1,5-a]喹啉衍生物
KR20210151849A (ko) 퀴놀린 유도체 및 암의 치료를 위한 그의 용도
EP3256120B1 (en) Psoralen derivatives as non-peptidic inhibitors of chymotrypsin-like activity of the immunoproteasome
MXPA97007574A (en) Method for inhibiting the growth of mamife cells
WO2017097215A1 (zh) 内嵌脲类结构的wnt通路抑制剂
JP5641054B2 (ja) 新規化合物、並びに、キネシンスピンドルタンパク質阻害剤及びその応用
EP1433789A1 (en) Pyrrolopyrazines and their use as selective apoptosis inducers

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force